News | September 09, 2007

Preclinical Researchers Take A 'New Point Of View'

September 10, 2007 - For the fourth year in a row, Siemens Medical Solutions, Molecular Imaging Division presented the Preclinical Image of the Year Awards this weekend at the Siemens Preclinical User's Group Meeting, held in Providence, R.I.

The competitive awards are the company's way of honoring pioneering researchers and their contributions. This year's entries demonstrated how advanced preclinical imaging solutions may shed new light on disease processes and potential treatment pathways. Images were acquired on Siemens Medical Solutions preclinical imaging systems: the multimodality Inveon preclinical scanner and the microPET (positron emission tomography) and microCAT (computed axial tomography) scanners, which have been long-time industry leaders.

Preclinical PET Image of the Year:
"In vivo FDG-PET imaging of glucose uptake in pressure overloaded mice to evaluate metabolic mechanism and cardiac function during myocardial hypertrophy," Acquired by Bijoy K. Kundu, Stuart S. Berr, G. Paul Matherne and Amy R. Lankford from the University of Virginia.

Preclinical CT Image of the Year:
"Imaging and analysis for the assessment of the normal mouse lung," acquired by Eric A. Hoffman, Geoffrey McLennan, Joseph M. Reinhardt, Gary E. Christensen, Deokiee Chon, Eman Namati, Jacqueline Namati, Lijun Shi, Joo Hyun Song, Kunlin Cao and Jered Sieren from the University of Iowa.

Preclinical Multimodality Image of the Year:
"Adenovirus validation in lymph node metastasis," acquired by J. Burton, M. Johnson, D. Stout and L Wu from the University of California, Los Angeles, Crump Institute for Molecular Imaging.

Most Innovative Preclinical Image of the Year:
"Micro-array or MicroPET?" acquired by K. Gagnon and J. Sutcliffe from the University of California, Davis.

For more information: www.usa.siemens.com/medical

Related Content

PET Tracer Gauges Effectiveness of Promising Alzheimer's Treatment

Longitudinal PET imaging with 18F-AV45. PET imaging shows the average 18F-AV45 uptake per animal group at 8 and 13 months of age. A significant interaction of genotype treatment was observed in the cortex (p = 0.0248), hippocampus (p = 0.0071) and thalamus (p = 0.0084), indicating reduced [18F]-AV45 uptake in BACE1 inhibited transgenic mice. Credit: MICA, University of Antwerp, Belgium.

News | Radiopharmaceuticals and Tracers | December 28, 2017
In the December featured basic science article in The Journal of Nuclear Medicine, Belgian researchers report on the...
Michael J. Fox Foundation and Tau Consortium Developing PET Tracers for Neurodegenerative Disease
News | Radiopharmaceuticals and Tracers | October 27, 2017
The Michael J. Fox Foundation for Parkinson's Research (MJFF) and the Tau Consortium announced a funding partnership to...
Videos | Nuclear Imaging | August 24, 2017
Prem Soman, M.D., director of nuclear cardiology at the Heart and Vascular Institute, University of Pittsburgh, and p
Study Demonstrates First Human Application of Novel PET Tracer for Prostate Cancer

Transaxial 11Csarcosine hybrid PET/CT showed a (triangulated) adenocarcinoma in the transition zone of the anterior right prostate gland on PET (A), CT (B), and a separately obtained T2?weighted MR sequence (C) with resulting PET/MRI registration (D). Image courtesy of M. Piert et al., University of Michigan, Ann Arbor, Mich.

News | Radiopharmaceuticals and Tracers | August 16, 2017
In the featured translational article in the August issue of The Journal of Nuclear Medicine, researchers at the...
Novel PET Tracer Detects Small Blood Clots

PET images (MIP 0-60 min) of three Cynomolgus monkeys. Strong signals are detected at the sites where inserted catheters had roughened surfaces. Almost no other background signal is visible. Only accumulation in the gallbladder becomes visible at the bottom of the image. Credit: Piramal Imaging GmbH, Berlin Germany.

News | PET Imaging | July 07, 2017
July 7, 2017 — Blood clots in veins a

While subject No. 1 (left) was judged as positive for both the neuronal injury and the amyloid load biomarker, both Alzheimer's disease biomarkers were negative in subject No. 2 (right). Image courtesy of Henryk Barthel et al., University Hospital Leipzig, Leipzig, Germany

News | PET Imaging | June 14, 2017
More people die of Alzheimer's disease than prostate and breast cancer combined. Identifying the disease before major...
News | Clinical Study | June 09, 2017
The milestone Imaging Dementia — Evidence for Amyloid Scanning (IDEAS) Study is working with government and academic...
Lantheus and GE Healthcare Sign Agreement for Worldwide Development, Commercialization of Flurpiridaz F-18
News | Radiopharmaceuticals and Tracers | May 22, 2017
May 22, 2017 — Lantheus Holdings Inc., parent company of Lantheus Medical Imaging Inc., and GE Healthcare announced t
low-dose lung CT scan

An example of a low-dose CT scan of the lungs, showing lung cancer. Image courtesy of Toshiba.

Feature | Lung Cancer | May 05, 2017 | Alison Grimes
The term mesothelioma was coined in 1909, just a few years after the introduction of medical X-ray imaging.
Australian Team Finds New Method for Producing PET Radiotracers in Higher Radiochemical Yields
News | Radiopharmaceuticals and Tracers | April 28, 2017
April 28, 2017 — Researchers at the Australian Nuclear Science and Technology Organisation (ANSTO) have led the devel
Overlay Init